메뉴 건너뛰기




Volumn 55, Issue 3, 2011, Pages 230-237

Molecular nuclear therapies for thyroid carcinoma

Author keywords

Astatate; I 131; Molecular targeted nuclear therapy; NIS; Nuclear medicine; Perrhenate; Radioiodine therapy; Somatostatin analogues; Thyroid carcinoma

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; COTRANSPORTER; IODINE 123; IODINE 124; IODINE 131; RADIOACTIVE IODINE; ROSIGLITAZONE; SODIUM IODIDE I 123; SODIUM IODINE SYMPORTER; SOMATOSTATIN DERIVATIVE; THYROID HORMONE; THYROTROPIN; UNCLASSIFIED DRUG;

EID: 82955163038     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2011.06.002     Document Type: Review
Times cited : (10)

References (154)
  • 4
    • 0029650182 scopus 로고
    • Seaborg G.T. JAMA 1995, 273:961-964.
    • (1995) JAMA , vol.273 , pp. 961-964
    • Seaborg, G.T.1
  • 14
    • 0001783640 scopus 로고    scopus 로고
    • Hormone synthesis: thyroid iodine metabolism
    • Lippincott Williams & Wilkins, Philadelphia, L.E. Braverman, R.D. Utiger (Eds.)
    • Taurog A. Hormone synthesis: thyroid iodine metabolism. The Thyroid 2000, 61-85. Lippincott Williams & Wilkins, Philadelphia. L.E. Braverman, R.D. Utiger (Eds.).
    • (2000) The Thyroid , pp. 61-85
    • Taurog, A.1
  • 93
    • 0000776443 scopus 로고
    • A method and rationale for treating metastatic thyroid carcinoma with the largest safe dose of I-131
    • Plenum Medical Book Co., New York, G. Medeiros-Neto, G. Gaitan (Eds.)
    • Benua R.S., Leeper R.D. A method and rationale for treating metastatic thyroid carcinoma with the largest safe dose of I-131. Frontiers in Thyroidology 1986, 1317-1321. Plenum Medical Book Co., New York. G. Medeiros-Neto, G. Gaitan (Eds.).
    • (1986) Frontiers in Thyroidology , pp. 1317-1321
    • Benua, R.S.1    Leeper, R.D.2
  • 126
    • 82955234354 scopus 로고    scopus 로고
    • European Medicines Agency, Committee for Medicinal Products for Human use Post-authorisation Summary of Positive Opinion for Thyrogen, European Medicines Agency, London
    • European Medicines Agency, Committee for Medicinal Products for Human use Post-authorisation Summary of Positive Opinion for Thyrogen, European Medicines Agency, London, 2009.
    • (2009)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.